⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRPT News
Sarepta Therapeutics,, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
accessnewswire.com
SRPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
accessnewswire.com
SRPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
accessnewswire.com
SRPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
accessnewswire.com
SRPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
accessnewswire.com
SRPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
accessnewswire.com
SRPT
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
businesswire.com
SRPT
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
businesswire.com
SRPT
Kuehn Law Encourages Investors of Sarepta Therapeutics, Inc. to Contact Law Firm
prnewswire.com
SRPT
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
prnewswire.com
IOBT
SRPT
AUTL
ARCT
IOBT
SRPT
AUTL
ARCT